Guided Therapeutics Inc
GTHP· OTC
Filed Apr 7, 2021 · 10-K · 97 days after period end · 0001654954-21-003915
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $16.00K | $43.00K | $103.00K |
| Net Income | $2.17M | $1.08M | -$2.74M | -$7.15M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Apr 7, 2021 · 97 d after period end